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the tumor, the subclavian artery is resected and reanastomosed end
to end or with a ringed polytetrafluoroethylene (6- or 8-mm) graft.
The sternal component of the sternocleidomastoid muscle must
be sutured back to the manubrium with heavy sutures when closing
the incision. If the spinal accessory, dorsal scapular, and long
thoracic nerves are preserved along with the trapezius, latissimus
dorsi, rhomboid, levator scapulae, and serratus anterior muscles,
this approach results in minimal shoulder dysfunction and cos-
metic defect despite resection of the inner part of the clavicle
(Figure 2).
Discussion
The anterior transclavicular approach with resection of the inner
part of the clavicle and extension of the incision along the third rib
gives excellent exposure from the thoracic inlet down to the
pulmonary hilum. This approach allows dissection of the cervical
structures and completion of the upper lobectomy and mediastinal
lymph node dissection through the same incision under excellent
conditions. Compared with the hemiclamshell approach, this ap-
proach provides excellent exposure to the distal subclavian vessels
and allows direct anterior and anterolateral approach to the spine
and brachial plexus. The anterior clavicular sparing approach
described by several authors, including Grunenwald and Spag-
giari,6 can provide adequate exposure to the thoracic inlet but
offers limited view of the upper mediastinum and often requires an
additional thoracotomy to perform the lobectomy and mediastinal
lymph node dissection. If the inner part of the clavicle is removed,
it is important, however, to preserve the spinal accessory, dorsal
scapular, and long thoracic nerves in the posterior cervical triangle
and to maintain the integrity of the trapezius, latissimus dorsi,
rhomboid, and serratus anterior muscles by avoiding a posterolat-
eral thoracotomy to obtain good cosmetic and functional results.
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Osteomalacia associated with a fibroblast growth factor–23 secreting
chest wall tumor
Subroto Paul, MD, Michael Kurtz, BS, and Steven J. Mentzer, MD, Boston, Mass
Clinical Summary
Apreviously healthy 32-year-old man had a 9-monthhistory of progressive rib, pelvic, and foot pain. Skel-etal radiographs and bone scintigraphy revealed mul-tiple fractures of the ribs, pelvis, and right foot.
Blood testing demonstrated low plasma phosphate levels (1.5
mg/dL; normal 2.4–5.0 mg/dL) but normal calcium (9.2 mg/dL;
normal 8.8–10.5 mg/dL) and immunoreactive parathyroid hor-
mone levels (39 pg/mL; normal 11–80 pg/mL). A 24-hour urine
collection demonstrated phosphaturia (1593 mg/24 hours; normal
500-1200 mg/24 hours), suggesting a phosphate wasting disorder.
Since 25 vitamin D (34 ng/mL; normal 20–57 ng/mL) and 1,25
vitamin D (19 pg/mL; 18–62 pg/mL) levels were within normal
limits, a recently recognized disorder of paraneoplastic fibroblast
growth factor (FGF)–23 production was investigated. Serum im-
munoassays for FGF-23 were initially found to be high normal
(173 RU/mL; normal 180 RU/mL), but levels obtained the day
of surgery were elevated (432 RU/mL).
As part of a systemic soft tissue and skeletal survey for an
FGF-23 secreting tumor, a chest computed tomographic scan dem-
onstrated an expansile and destructive lesion in the right posterior
eighth rib (Figure 1, A). A fine needle aspiration biopsy revealed
benign spindle cells with osteoclast-like cells and hemosiderin
deposition.
Because no other bony or soft tissue tumors were identified,
surgical resection of the chest wall tumor was recommended. At
the time of surgery, thoracoscopic examination of the tumor dem-
onstrated neovascularization of the parietal pleura (Figure 1, B). A
complete excision of the chest wall mass required excision of a
portion of the eighth rib (Figure 1, C). Gross evaluation of the
tumor demonstrated multiple cystic spaces. The patient had an
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uneventful recovery and was discharged on the second postoper-
ative day.
Histopathologic examination of the mass revealed a spindle cell
proliferation with features of an aneurysmal bone cyst (Figure 1, D).
In the context of elevated FGF-23 levels, the histopathologic
features were consistent with those of a phosphaturic mesenchy-
mal tumor. Postoperatively, phosphate (4.5 mg/dL), urine phos-
phate (1066 mg/24 h), and FGF-23 (FGF-23 50 RU/mL to
undetectable) levels normalized and remain normal 6 months
postoperatively.
Discussion
Acquired “fragile bone syndromes” reflect abnormalities in cal-
cium and phosphate metabolism. The primary regulators of cal-
cium and phosphate homeostasis are vitamin D and parathyroid
hormone. Vitamin D deficiency—whether a result of dietary in-
sufficiency (ricketts), malabsorbtion, renal dysfunction or drug
interactions—demonstrates a low level of the active form of
vitamin D (1,25-dihydroxy vitamin D3; Calcitriol). In contrast,
hyperparathyroidism will reflect an elevated immunoreactive para-
thyroid hormone level. In patients with normal vitamin D and
parathyroid hormone serum levels, bone wasting may be due to a
paraneoplastic etiology.
The constellation of an identifiable tumor and bone wasting has
been referred to as oncogenic osteomalacia. Although the first
report described a chest wall tumor, 104 of the 109 cases reviewed
by Folpe and associates1 were found in the extremities, head, or
neck. Isolated case reports have described tumors in the lung,
mediastinum, thoracic spine, and rib.1 In a study of patients with
oncogenic osteomalacia, Jonsson and colleagues2 have described 5
of 6 patients with markedly elevated levels of FGF-23.
With an improved understanding of their biologic activity,
recent classification systems have described the tumors associated
with oncogenic osteomalacia as phosphaturic mesenchymal tumor,
mixed connective tissue variant or PMTMCT.3 Common to these
tumors is a paraneoplastic syndrome associated with marked phos-
phaturia. PMTMCT tumors are locally expansile and destructive,
but rarely associated with metastatic disease. When the primary
tumor is not identifiable by conventional radiographic imaging,
octreotide scanning may be useful to localize the site of the lesion.4
When an FGF-23 secreting tumor is identified, surgical resec-
tion is the treatment of choice. Preoperative therapy with oct-
reotide has been advocated as a strategy to suppress the production
of FGF-23 and minimize perioperative metabolic complications.
Consistent with other reports, the margins of this tumor were
readily assessed at surgery and a complete resection was obtained
with limited morbidity.
The present case illustrates an improved understanding of both
the etiology of oncogenic osteomalacia and the biology of tumor-
associated angiogenesis. Recent studies have suggested that most
cases of oncogenic osteomalacia are paraneoplastic syndromes
associated with FGF-23 production.2 FGF-23 is a member of the
FGF molecular family. FGF family members are involved in a
variety of biologic processes including morphogenesis, tissue re-
pair, and tumor growth and invasion. In this patient, the excessive
production of FGF-23 may have contributed an autocrine effect;
that is, FGF-23 may have contributed not only to pathologic
posphaturia, but also to neovascularization and tumor progres-
sion.5 Regardless of the biologic effects, the paraneoplastic pro-
duction of FGF-23 provides a useful serum marker for both diag-
nostic confirmation and postresectional surveillance.
References
1. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho
JY, et al. Most osteomalacia-associated mesenchymal tumors are a
Figure 1. Patient with FGF-23 secreting tumor.
A, Computed tomographic scan demonstrating a
lesion in the right posterior chest wall (circle).
B, Thoracoscopic appearance of the tumor: note
the prominent neovascularization of the overly-
ing parietal pleura. C, The lesion was completely
excised with the limited resection of two ribs.
D, Histopathologic analysis demonstrated spin-
dle cells and aneurysmal bone cysts.
Brief Communications
804 The Journal of Thoracic and Cardiovascular Surgery ● September 2007
single histopathologic entity: an analysis of 32 cases and a comprehen-
sive review of the literature. Am J Surg Pathol. 2004;28:1-30.
2. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T,
Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteo-
malacia and X-linked hypophosphatemia. N Engl J Med. 2003;348:
1656-63.
3. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A poly-
morphous group causing osteomalacia or rickets. Cancer. 1987;59:
1442-54.
4. Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, et al.
Octreotide therapy for tumor-induced osteomalacia. N Engl J Med.
2001;345:1883-8.
5. Carpenter TO. Oncogenic osteomalacia—a complex dance of factors.
N Engl J Med. 2003;348:1705-8.
Staged closure of tracheogastrocutaneous fistula after esophagectomy
for infiltrative granular cell tumor
Robert Merritt, MD,a Steven M. Zeitels, MD,a William G. Austen, Jr, MD,a Gregory Y. Lauwers, MD,b and
Henning A. Gaissert, MD,a Boston, Mass
We report a tracheogastrocutaneous fistula and bi-lateral vocal cord paralysis after resection of anesophageal tumor. Reconstruction in 2 stages re-stored voice and swallowing.
Clinical Summary
A 22-year-old woman with a normal voice presented with a 3-year
history of progressive dysphagia to solids and choking. A com-
puted tomographic scan (Figure 1) showed a 3.8  1.7– cm esoph-
ageal wall mass compressing the trachea. A submucosal mass was
found on endoscopy; biopsy was nondiagnostic. A cervical inci-
sional biopsy specimen was interpreted as a benign granular cell
tumor (GCT). The patient sought a second opinion and underwent
neck re-exploration with tracheostomy. A second biopsy specimen
was read as a malignant GCT. The mass was resected during a
third procedure by dividing the trachea to provide access for total
esophagectomy and posterior window resection of the trachea.
After esophageal anastomosis in the neck to stomach, the cartilag-
inous trachea was closed and tracheal continuity was restored. The
patient awoke hoarse from the operation. One week later, a fistula
presented between the trachea and esophageal anastomosis.
In 4 additional procedures, skin flaps from the neck and left
forearm were raised to close the fistula in the tracheal stoma, each
of which was unsuccessful. The final attempt at closure 5 months
after resection included division of the trachea with closure of the
larynx and cutaneous end stoma. She presented to Massachusetts
General Hospital requiring constant suction of gastric secretions
from the tracheal stoma. Bilateral vocal cord palsy was noted on
laryngoscopy, and the subglottic lumen was closed below the
cricoid. The 3-cm-long native esophagus ended in the 2-cm-wide
fistula between the gastric mucosa and the membranous portion of
the trachea. Gastric secretions freely washed into the trachea and
drained from the cutaneous stoma. The residual trachea was 7 cm
long, with inflamed mucosa.
The first stage of reconstruction closed the fistula 1 year after
esophagectomy (Figure 2). By using a cervicomediastinal ap-
proach, the stomach was separated from the trachea, closed in the
posterior mediastinum, and covered with pectoral muscle. Intesti-
nal continuity was restored with substernal colon and colojejunos-
tomy. Evaluation after recovery showed persistent vocal cord palsy
in midabduction but no aspiration. The patient maintained her
weight on an oral diet.
For tracheal reconstruction 5 months later, the cricoid was
opened, and the distal trachea was mobilized for end-to-end anas-
tomosis. After intubation for 3 days, a small tracheostomy was
placed. The patient was discharged without stridor, leaving a
stomal stent that was removed 4 months later. The patient now has
a well-modulated voice without hoarseness. An uneventful lower
body lift under endotracheal anesthesia has since been performed
for cosmetic reasons.
Histologic review of the outside specimen at Massachusetts
General Hospital established an infiltrative GCT of the esophagus
(Figure 3). The tumor extensively involved the muscularis propria
and adventitia and was present at the cervical and soft tissue
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